Studies have demonstrated that snRNAs derived from exosomes in lung cancer or melanoma can facilitate the establishment of a premetastatic microenvironment by activating Toll-like receptor 3 (TLR3) and promoting the release of cytokines. The gene discussed is TLR3; the disease is melanoma.